Limbix
AcquiredDigital therapeutics for adolescent mental health
San Francisco, United States · Founded 2016 · $24.0M raised
- Headquarters
- San Francisco, California
- Employees
- 11–50
- Founded
- 2016
- Website
- limbix.com
- Total Funding
- $24.0M
- Last Round
- $15.0M Series ADec 2021
- Rounds
- 2
About
Limbix is a prescription digital therapeutics company focused on adolescent mental health. Founded in 2016 and headquartered in Palo Alto, California, it developed SparkRx — a cognitive behavioral therapy (CBT)-based digital therapeutic program for teens and young adults experiencing symptoms of depression. Limbix pairs clinical expertise with technology, employing clinicians, product designers, researchers, and engineers focused on delivering accessible mental health treatment to young people. The company raised $31 million in a Series A and was acquired by Big Health in July 2023.
Summary
Limbix is a Healthcare company based in San Francisco, United States, founded in 2016. It has raised $24.0M in total across 2 rounds, most recently a $15.0M Series A round in Dec 2021.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jul 2023
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Similar Companies
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...
Healthcare company in Europe